跳至主要内容
临床试验/NCT04843813
NCT04843813Unknown不适用

Lutein and Multiple Sclerosis Experimental Study (LuMES)

University of Illinois at Urbana-Champaign1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年3月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Macular Pigment Optical Density

研究概览

简要总结

The central hypothesis is that lutein supplementation will improve MPOD and cognition. Accordingly, the specific aims are to 1) to determine the process feasibility associated with participating in 4-month lutein supplementation trial; and 2) to investigate the scientific feasibility of 4-month daily lutein supplementation on biological markers of lutein status and cognitive function among persons with MS.

详细描述

A two-group parallel design will be employed whereby participants will be randomly assigned to one of 2 groups. The supplementation doses 20mg/d (Group 1), and placebo (Group 2) will be consumed daily by the participant for a 4-month period. Pre-test and follow-up measures of lutein status and cognitive function will be assessed at baseline and at 4-month follow-up via laboratory visits.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18-64.9 years
  • •Self-reported relapsing-remitting MS (RRMS) diagnosis
  • •Expanded Disability Status Scale (EDSS) score between 0-3.5
  • •Macular Pigment Optical Density at baseline (MPOD ≤0.35)
  • •Score ≤55 during the Symbol Digit Modalities Test (SDMT)
  • •20/20 or corrected vision
  • •No presence of color blindness
  • •No history of age-related macular degeneration
  • •No history of epileptic seizures

排除标准

  • •Under 18 years or over 64.9 years
  • •MS diagnosis other than RRMS
  • •Pregnancy
  • •Uncorrected vision
  • •Presence of color blindness
  • •PDDS score of 7 or more
  • •Prior diagnosis of age-related macular degeneration
  • •History of epileptic seizures

研究组 & 干预措施

Safflower Oil

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

Lutein

Experimental

干预措施: Lutein (Dietary Supplement)

结局指标

主要结局

Macular Pigment Optical Density

时间窗: 4 months (baseline vs. follow-up)

Changes in Macular Pigment Optical Density (log units) between groups using a macular densitometer

Attentional Accuracy

时间窗: 4 months (baseline vs. follow-up)

Changes in accuracy (%) between groups using a computerized flanker task

Attentional Reaction Time

时间窗: 4 months (baseline vs. follow-up)

Changes in reaction time (ms) between groups using a computerized flanker task

Attentional Resource Allocation

时间窗: 4 months (baseline vs. follow-up)

Changes in P3 event related potential amplitude (microvolts) between groups using a computerized flanker task

Attentional Processing Speed

时间窗: 4 months (baseline vs. follow-up)

Changes in P3 event related potential latency (ms) between groups using a computerized flanker task

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Naiman Khan

Assistant Professor

University of Illinois at Urbana-Champaign

研究点 (1)

Loading locations...

相似试验